Yes.

Fertility declines steeply from the mid-30s, but a decline is not the same as sterility, and every major contraception guideline treats perimenopause as a time when effective contraception is still needed. Pregnancy is less common at this age but not rare, and pregnancies that do occur carry a higher risk of complications such as miscarriage. Most guidelines set age 55 as the point by which essentially all women can safely stop, with some methods allowing an earlier stop under specific conditions. This is guideline-level consensus, not a personal prediction, so it is worth reviewing your own situation with a clinician.

What to know about this answer

The real disagreement is not whether pregnancy is possible, since population data settle that, but the source material flags one dissenting view in the field that the pregnancy-risk conversation is overused and may distract from a different issue: inadequate estrogen dosing.

What the research shows, and which source each finding rests on

Effective contraception is recommended until menopause, because spontaneous pregnancy, while rare after age 50, is not eliminated; sterility cannot be assumed until at least age 60, since spontaneous pregnancies have been reported in women up to age 59.

A[1]A[2]

In 2015, 28.1% of recorded pregnancies in women aged 40 and older in England and Wales resulted in a therapeutic abortion.

A[1]

The US pregnancy rate for women aged 40 and older reached a historic high of 19 per 1,000 women in 2019.

E[3]

The universal stopping backstop across guidelines: all women can stop contraception at age 55; for non-hormonal methods, stopping after 2 years without a period is supported at ages 40-50, and after 1 year over age 50.

A[1]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

contraception is still clearly needed

guideline bodies and clinicians quoted in the source material

Guidelines and clinical experience agree spontaneous pregnancy remains possible well into the late 40s and occasionally the 50s; one quoted clinician described delivering twins to a 52-year-old who believed she was already in menopause.

E[4]

the pregnancy-risk framing is overstated

an unnamed speaker in the source material's expert-video corpus (identity uncertain)

This view holds that women in their 40s are not meaningfully at risk of pregnancy and that low-dose pills mainly function as a small, likely inadequate dose of estrogen rather than as genuine contraception.

A[1]

What would settle it: The population pregnancy and abortion data already answer the pregnancy-risk question; whether estrogen dosing for symptom relief is being adequately addressed alongside contraception is a separate, unresolved clinical conversation.

What is really going on here

  1. The guideline's own residual-pregnancy-probability figures (roughly 10-20% per year at 40-44, closer to 12% at 45-49) are internally hard to reconcile and come from narrative reviews rather than primary data, so treat them as a wide-range estimate, not a precise number.
  2. Population outcome statistics, such as abortion rates and historic pregnancy-rate highs, describe what actually happens and are more reliable to quote than the modeled annual probability.

Questions for your doctor

  1. Given my age, cycle pattern, and health history, when could I safely consider stopping contraception?
  2. Which contraceptive methods are safest for me specifically, given my risk factors?
  3. If my periods stop, how long should I wait before considering contraception no longer necessary?
  4. Does the method I am using now still make sense for where I am in the transition?

Questions with no answer yet

Is the guideline's own residual-pregnancy-probability figure of closer to 12% at ages 45-49 actually accurate, given how close it sits to the 40-44 estimate despite the steep fertility decline documented elsewhere in the same guideline?

Partly studied

What is known: The guideline's own residual-pregnancy-probability figures, roughly 10-20% per year at 40-44, closer to 12% at 45-49, come from narrative reviews rather than primary data and are internally hard to reconcile with the steepness of the fertility decline described elsewhere in the same guideline.

What would test it: A primary population study directly measuring per-cycle or per-year conception probability in women aged 45-49 with regular unprotected intercourse, rather than relying on narrative-review estimates.

Does inadequate estrogen dosing, rather than genuine pregnancy risk, explain some of the reasoning behind keeping perimenopausal women on low-dose contraceptive pills?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: One view recorded in the source material holds that low-dose pills in this age group mainly function as a small, likely inadequate dose of estrogen rather than as meaningful contraception; the population pregnancy and abortion data clearly establish that pregnancy risk is real, but whether estrogen-dose adequacy is a separate, underaddressed issue running alongside the contraception conversation has not been studied.

What would test it: A study directly comparing symptom control on contraceptive-dose versus standard hormone-therapy-dose estrogen in perimenopausal women who also have reliable contraception in place.

Sources

  1. 1.FSRH. Contraception for Women Aged Over 40 Years. Guideline, August 2017 (amended September 2019, further amended July 2023).Systematic review or guideline
  2. 2.Contraception during the perimenopause.Baldwin MK, Jensen JT. Contraception during the perimenopause. Maturitas 2013;76(3):235-42. · Systematic review or guideline
  3. 3.Guttmacher Institute. Pregnancies, Births and Abortions in the United States, 1973-2020: National and State Trends by Age.Review, opinion or mechanism
  4. 4.Corinne Menn, DO. Perimenopause 101 (video transcript).Review, opinion or mechanism

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides